Diagnosis and management of infectious complications in critically ill patients with cancer

Critical Care Clinics
Raghukumar ThirumalaSanjay Chawla

Abstract

Cancer and its treatments lead to profound suppression of innate and acquired immune function. In this population, bacterial infections are common and may rapidly lead to overwhelming sepsis and death. Furthermore, infections caused by viral and fungal pathogens should be considered in patients who have specific immune defects. As cancer therapies have become more aggressive the risk for infection has increased and many patients require intensive care support. Despite improvements in long-term survival, infections remain a common complication of cancer therapy and accounts for the majority of chemotherapy-associated deaths. By understanding the host defense impairments and likely pathogens clinicians will be better able to guide diagnosis and management of this unique population.

References

May 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J A CapdevilaJ M Martínez-Vázquez
Apr 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A LeccionesT J Walsh
Jun 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L S EltingB H Keefe
May 1, 1992·Journal of Pediatric Surgery·B W DuncanM R Harrison
Sep 20, 1990·The New England Journal of Medicine·P J Schilling, S Vadhan-Raj
Sep 1, 1987·Reviews of Infectious Diseases·M M FrankC Hammer
Jul 28, 1986·The American Journal of Medicine·G P Bodey
Jul 1, 1986·The American Journal of Medicine·B PolskyD Armstrong
May 1, 1974·Cancer·A S DeinardB J Kennedy
Mar 1, 1984·Neurology·S A LukesD Armstrong
Feb 1, 1994·British Journal of Haematology·J CebonG Morstyn
Oct 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·S J GallacherA C MacCuish
Jan 1, 1997·Mycoses·S Schwartz, E Thiel
Apr 29, 1998·The American Journal of Medicine·E J AnaissieS Vartivarian
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S Johnson, D N Gerding
Oct 3, 1998·Annals of Internal Medicine·E J AnaissieM J Keating
Aug 12, 1999·Journal of Pediatric Surgery·J BaergJ F Magee
Sep 29, 1999·Intensive Care Medicine·A BouchamaK Shukri
Oct 12, 1999·Respiration; International Review of Thoracic Diseases·S W Crawford
Mar 7, 2000·The Journal of Antimicrobial Chemotherapy·I Raad
Oct 29, 2000·Seminars in Neurology·M Gottfredsson, J R Perfect
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S J LinS M Teutsch
Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Q NguyenE Whimbey
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Apr 9, 2001·Critical Care Medicine·D K Warren, V J Fraser
May 31, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L A MermelUNKNOWN Society for Healthcare Epidemiology of America
Jul 13, 2001·Infectious Disease Clinics of North America·F ParadisiR Cinelli
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M GorschlüterI G Schmidt-Wolf
Aug 30, 2001·Critical Care Clinics·A Safdar, D Armstrong
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases

❮ Previous
Next ❯

Citations

Jun 13, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·P Schellongowski, T Staudinger
Mar 16, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·T Staudinger
Feb 28, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·T Staudinger, P Schellongowski
Aug 31, 2013·Current Hematologic Malignancy Reports·Michael K Keng, Mikkael A Sekeres
Mar 23, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ursula Theuretzbacher
Aug 27, 2013·Der Internist·M KochanekM von Bergwelt-Baildon
Oct 23, 2015·Expert Review of Anti-infective Therapy·Ligia S C F RabelloJorge If Salluh
Mar 1, 2014·Expert Review of Vaccines·Gregory P Priebe, Joanna B Goldberg
Apr 14, 2016·Memo·Peter SchellongowskiUNKNOWN Intensive Care in Hematologic-Oncologic Patients (iCHOP)
Jan 5, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·N AliM U Shaikh
May 23, 2015·Medizinische Klinik, Intensivmedizin und Notfallmedizin·I SuárezM Kochanek
Aug 23, 2011·Journal of Critical Care·Maíra M RosolemMárcio Soares
Nov 6, 2018·Surgical Infections·Christina MerakouGregory P Priebe
Feb 1, 2018·BMC Research Notes·Segal Abdul AzizSuhendro Suhendro
Apr 17, 2019·International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition·Sanaz TavasoliAmir-Hassan Zarnani
Aug 1, 2013·Physiological Reviews·Kendra N IskanderDaniel G Remick
Feb 1, 2011·Continuum : Lifelong Learning in Neurology·Matthew McCoyd, Gregory Gruener
Aug 2, 2019·Human Vaccines & Immunotherapeutics·Sarah M BakerLisa A Morici
Sep 12, 2012·Current Opinion in Infectious Diseases·Iain J Abbott, Jason A Roberts
Dec 15, 2018·Polish Journal of Microbiology·Mikołaj MichnoWładysław Sułowicz
Jan 1, 2011·Wiener Klinische Wochenschrift. Education·Peter Schellongowski
Nov 28, 2020·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Arwa Nada, Jennifer G Jetton
Jun 1, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L A HajjarP M Hoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Brain Abscess

Brain abscess is an accumulation of pus caused by inflammation and infected materials in the brain. Symptoms include fever, headache, seizures and other neurological problems. Discover the latest research on brain abscess today.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.